Study to Assess the Efficacy of Tradipitant in Relieving Symptoms of Gastroparesis
-
- STATUS
- Enrolling By Invitation
Summary
The main purpose of this study is to see if an experimental drug, TRADIPITANT can help people with diabetic or idiopathic gastroparesis who are suffering from nausea.
Description
Who is eligible? • Patients with idiopathic or diabetic gastroparesis with moderate to severe nausea • Patients must have had nausea symptoms for at least 6 months If you participate in the study you will receive the following: Physical examinations, laboratory tests, study related medications. All procedures and medication are provided at no charge to you. How long will I be in the study? The total time in the study could be up to approximately 9 weeks. Will I be paid to be in the study? Patients will be compensated for time and travel.
FAQ
Details
| Condition | Nausea,Vomiting,Gastroparesis |
|---|---|
| Age | 18years - 70years |
| Clinical Study Identifier | TX5559 |
| Last Modified on | 19 February 2024 |
Eligibility
How to participate?
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.